VANCOUVER, Aug. 31, 2016 /CNW/ - Aurora Cannabis Inc. (CSE: ACB) (FRANKFURT: 21P) (WKN: A1C4WM) (OTCQB: ACBFF) ("Aurora" or the "Company"), announced that all resolutions presented to the Company's shareholders at its Annual General Meeting (AGM), which was held August 26, 2016, were passed.
Votes representing 42,985,566 shares were cast (31.69% of the issued and outstanding shares at the record date). All six directors proposed at the meeting were voted in with a share of the vote in excess of 99.5%. Additionally, the other motions at the meeting, namely reappointment of the auditors, and the Company's stock option plan, were carried with over 99.5% of the vote as well.
Following the AGM, the Company's Board of Directors has the following members: Terry Booth, Steve Dobler, Chuck Rifici, Adam K. Szweras, Jason Dyck, and Michael Singer.
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical marijuana pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) and operates a 55,200 square foot, expandable, state-of-the-art production facility in Alberta, Canada. Aurora trades on the Canadian Securities Exchange under the symbol "ACB".
On behalf of the Board of Directors, AURORA CANNABIS INC.
Terry Booth, CEO
The CSE or other regulatory authority has not reviewed, approved or disapproved the contents of this press release. We seek Safe Harbour.
SOURCE Aurora Cannabis Inc.
For further information: Cam Battley, Senior VP Communications and Medical Affairs, +1.905.864.5525, [email protected], www.auroramj.com; Marc Lakmaaker, NATIONAL Equicom, +1.416.848.1397, [email protected]